U.S., Jan. 14 -- An application to own the trademark for 'EXOEDIT' has been filed on Jun. 18, 2024.
Owner(s):
Evox Therapeutics Limited; Oxford Science Park, Medawar Centre,, 2nd Floor East Building, Robert Robinson Avenue Oxford, Oxfordshire OX4 4HG, UNITED KINGDOM
Goods and/or Services:
For: Pharmaceuticals for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies being mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal ...